Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Daiichi Sankyo
US Department of Justice
Accenture
Cipla
Fish and Richardson
Medtronic
Harvard Business School

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022247

« Back to Dashboard

NDA 022247 describes DUAVEE, which is a drug marketed by Wyeth Pharms Pfizer and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug. Additional details are available on the DUAVEE profile page.

The generic ingredient in DUAVEE is bazedoxifene acetate; estrogens, conjugated. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bazedoxifene acetate; estrogens, conjugated profile page.
Summary for 022247
Tradename:DUAVEE
Applicant:Wyeth Pharms Pfizer
Ingredient:bazedoxifene acetate; estrogens, conjugated
Patents:4
Formulation / Manufacturing:see details
Pharmacology for NDA: 022247
Suppliers and Packaging for NDA: 022247
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-1123 N 0008-1123-12
DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247 NDA U.S. Pharmaceuticals 63539-122 N 63539-122-07

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE;0.45MG
Approval Date:Oct 3, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 13, 2018
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:➤ Try a Free TrialPatent Expiration:Apr 4, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
Patent:➤ Try a Free TrialPatent Expiration:May 6, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
AstraZeneca
Deloitte
Boehringer Ingelheim
Johnson and Johnson
Moodys
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.